Investing Profile

Stacey Seltzer

VC
Partner at Gurnet Point Capital
Photo of Stacey Seltzer, Partner at Gurnet Point Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
5844 CONNECTIONS
Hotmail Network
5844 CONNECTIONS
Hotmail Network
5844 CONNECTIONS
Hotmail Network
5844 CONNECTIONS
The Wharton School Network
828 CONNECTIONS
cb
3
CompanyStageDateRound SizeTotal Raised
Aimmune Therapeutics
Series BMar 2015$80M
$80M
Co-investors: Jim Tananbaum (Foresite Capital Management)
Agile Therapeutics
Post Ipo EquityFeb 2015$20M
Series CJul 2012$40M
$110M
Co-investors: Karen Hong (De Novo Ventures), Andrew Schiff (Aisling Capital)
Business Analyst HotmailPresent
Director, Business Development HotmailPresent
Board Member HotmailPresent
Managing Partner and Founder HotmailPresent
Business Analyst Mckinsey & CompanyPresent
Director, Business Development AkceliPresent
Director, Business Development Mckinsey & CompanyPresent
Management Associate MerckPresent
Senior Manager, Global Licensing MerckPresent
Associate Director, US Marketing MerckPresent
Principal Aisling CapitalPresent
Board Member Mckinsey & CompanyPresent
Board Member Aimmune TherapeuticsPresent
Board Member Reneo PharmaceuticalsPresent
Partner Aisling CapitalPresent
Partner Gurnet Point CapitalPresent
Managing Partner and Founder Mckinsey & CompanyPresent
Yale University M.S. / B.S. Molecular Biophysics and Biochemistry
Wharton School of Business MBA Healthcare
The Wharton School MBA Healthcare
Sign in with Google →
Sign in with Google →